The pezcoller lecture: Cancer cell cycles revisited

Cancer Research

Volumn 60, Issue 14, 2000, Pages 3689-3695

  Sherr, C J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN DEPENDENT KINASE; CYCLIN E; ENZYME INHIBITOR; PROTEIN MDM2; PROTEIN P16; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONFERENCE PAPER; GENE ACTIVATION; GROWTH INHIBITION; HUMAN; MITOGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR RESISTANCE;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; G1 PHASE; HUMANS; MICE; MITOSIS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEINS; RETINOBLASTOMA PROTEIN; S PHASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034660892     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (118)

1. G1 events and regulation of cell proliferation
2. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
3. Human D-type cyclin
4. A novel cyclin encoded by a bcll-linked candidate oncogene
5. PSKJ3/CDK4) for mammalian D-type G1 cyclins
6. Identification of a G1 kinase activity for cdk6, a novel cyclin D partner
7. 1 cyclins
8. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
9. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase, CDK4
10. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
11. Retinoblastoma protein recruits histone deacetylase to repress transcription
12. Rb interacts with histone deacetylase to repress transcription
13. Retinoblastoma protein represses transcription by recruiting histone deacetylase
14. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSW1/SNF and Rb-hSW1/SNF
15. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
16. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family
17. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast
18. Association of human cyclin E with a periodic G1-S phase protein kinase
19. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle
20. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
21. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein
22. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation
23. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2
24. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein
25. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two cyclin-cdk complexes
26. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes
27. Cyclin/cdk-dependent initiation of DNA replication in a human cell-free system
28. WAF1, a potential mediator of p53 tumor suppression
29. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
30. p21 is a universal inhibitor of cyclin kinases
31. Kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
32. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
33. p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21
34. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
35. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene
36. Inhibitors of mammalian G1 cyclin-dependent kinases
37. Formation of p27-CDK complexes during the human mitotic cell cycle
38. Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4
39. New functional activities for the p21 family of CDK inhibitors
40. Kip1 CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts
41. Positive and negative regulation by CDK inhibitors
42. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
43. Cyclin E-CDK2 is a regulator of p27Kip1
44. Kip1
45. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
46. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome
47. Kip1 is haplo-insufficient for tumour suppression
48. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
49. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
50. INK4a/CDKN2A tumor suppressor and its relatives
51. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
52. Retinoblastoma protein-dependent cell cycle inhibition by the tumor suppressor p16
53. ink4 requires functional retinoblastoma protein
54. A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/CDK4
55. INK4B is a potential effector of TGFβ-induced cell cycle arrest
56. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
57. Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4
58. A cell cycle regulator involved in genesis of many tumor types
59. INK4a tumor suppressor versus other INK4 family members during mouse development and aging
60. INK4d-deficient mice are fertile despite testicular atrophy
61. Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis
62. ARF, is a candidate for the plasmacytoma susceptibility locus
63. Cancer cell cycles
64. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
65. ARF
66. INK4a transcript
67. Complex structure and regulation of the p16(MTS1) locus
68. INK4/MTS1 gene transcript expressed in B-cell malignancies
69. Role of the INK4a locus in tumor suppression and cell mortality
70. Tumor spectrum in ARF-deficient mice
71. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
72. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
73. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts
74. p53: Puzzle and paradigm
75. p53, the cellular gatekeeper for growth and division
76. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
77. ARF, participates in a regulatory feedback loop with p53 and MDM2
78. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53
79. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppressor pathways
80. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
81. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
82. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
83. Mdm2 expression is induced by wild type p53 activity
84. The p53-mdm-2 autoregulatory feedback loop
85. ARF with Mdm2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53
86. ARF stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2
87. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53
88. Nucleolar Arf sequesters Mdm2 and activates p53
89. Mdm2 promotes the rapid degradation of p53
90. Regulation of p53 stability by Mdm2
91. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding
92. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
93. ARF tumor suppressor
94. ARF links pRB and p53
95. ARF links the tumour suppressor p53 to ras
96. Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
97. Tumor surveillance via the ARF-p53 pathway
98. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
99. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis
100. Impact of 1NK4a/ARF and p53 mutations during lymphoma development and therapy
101. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc induced apoptosis via INK4a/ARF
102. Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion
103. Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled Atm function
104. MDM2 suppresses p73 function without promoting p73 degradation
105. Interactions between the retinoblastoma protein and the oncoprotein mdm2
106. RB regulates the stability of the apoptotic function of p53 via MDM2
107. p300/MDM2 complexes participate in MDM2-mediated p53 degradation
108. Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein
109. Identification of a cryptic nucleolar-localization signal in MDM2
110. Cooperative signals governing ARF-Mdm2 interaction and nucleolar localization of the complex
111. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
112. Differential regulation of E2F transactivation by cyclin/cdk2 complexes
113. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists
114. A ribonucleotide reductase gene involved in p53-dependent cell-cycle checkpoint for DNA damage
115. p53 sends nucleotides to repair DNA
116. Safety and antitumor activity of recombinant soluble Apo2 ligand